Company page

Caribou Biosciences, Inc.

Caribou Biosciences, Inc. (ticker: CRBU) is a public biotechnology company based in the United States, focusing on innovative gene-editing technologies. With a market capitalization of approximately $162.7 million, the company is positioned within the growing field of genetic research and development. Caribou aims to advance its proprietary technologies to address various medical challenges.